Does Green-Lipped Mussel Joint Function Randomized Trial work?

Updated October 2026

Quick Answer

Green-Lipped Mussel Joint Function Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: Background Knee osteoarthritis (OA) is a prevalent degenerative joint disease associated with pain, functional limitation, and reduced quality of life.

Key Takeaways

  • 01Background Knee osteoarthritis (OA) is a prevalent degenerative joint disease associated with pain, functional limitation, and reduced quality of life. [Kim HT (2026)]
  • 02Significant between-group differences were also observed for WOMAC pain (p = 0.026), WOMAC physical function (p = 0.027), and VAS pain (between-group difference - 19.93 mm; 95% CI - 25.31 to - 14.55; p Conclusions Twelve-week supplementation with GLMP was associated with improvements in pain and physical function in adults with mild-to-moderate knee OA. [Kim HT (2026)]
  • 03Although nonsteroidal anti-inflammatory drugs are widely prescribed, long-term use is limited by safety concerns. [Kim HT (2026)]
  • 04Fucoidan, an extract from seaweed Undaria pinnatifida , has been found to have beneficial effects on joint pain and insulin resistance. [Tay A (2022)]
The current Migaku evidence database contains 2 reusable source documents for Green-Lipped Mussel Joint Function Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove. - Background Knee osteoarthritis (OA) is a prevalent degenerative joint disease associated with pain, functional limitation, and reduced quality of life. [Kim HT (2026); evidence level 2] - Significant between-group differences were also observed for WOMAC pain (p = 0.026), WOMAC physical function (p = 0.027), and VAS pain (between-group difference - 19.93 mm; 95% CI - 25.31 to - 14.55; p Conclusions Twelve-week supplementation with GLMP was associated with improvements in pain and physical function in adults with mild-to-moderate knee OA. [Kim HT (2026); evidence level 2] - Although nonsteroidal anti-inflammatory drugs are widely prescribed, long-term use is limited by safety concerns. [Kim HT (2026); evidence level 2] - Fucoidan, an extract from seaweed Undaria pinnatifida , has been found to have beneficial effects on joint pain and insulin resistance. [Tay A (2022); evidence level 2] - Introduction Pharmaceutical drugs are beneficial to inflammatory conditions but with side effects, which led to the search for alternative therapies. [Tay A (2022); evidence level 2] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. Efficacy and safety of green-lipped mussel powder supplementation in adults with knee osteoarthritis: a randomized, double-blind, placebo-controlled trial.
  2. Combining mussel with fucoidan as a supplement for joint pain and prediabetes: Study protocol for a randomized, double-blinded, placebo-controlled trial.